Our Pros Knew GFA, INCY, ARNA and FBN Would Be Top Gainers on Monday
LONDON -- (Marketwire) -- 01/15/13 --
Wall Street Active pro-traders will be assisting investors today on GFA, INCY, ARNA and FBN, and provide insight based on their extensive experience so that you can boost your stock portfolio on the short-term or the long-term. If you are a shareholder in any of these companies do not miss this once in a life time opportunity, as our trading experts can show how to turn $5,000 into $35,000.
Gafisa S.A. (NYSE: GFA) closed at $4.92 on Monday, up 6.49%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Incyte Corporation (NASDAQ: INCY) closed at $19.22 on Monday, up 5.60%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Arena Pharmaceuticals Inc. (NASDAQ: ARNA) closed at $10.20 on Monday, up 5.60%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Furniture Brands International Inc. (NYSE: FBN) closed at $1.21 on Monday, up 5.22%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.
Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com
Source: Wall Street Active
SHARE THIS:
SHORT URL: http://bdvt.co/Evn
MEDIA
No media uploaded.
INFO
About
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs for oncology and inflammation. The company offers JAKAFI, an oral janus associated kinase inhibitor for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF. The company
Press Release $INCY Incyte Corporation
LONDON -- (Marketwire) -- 01/15/13 -- Wall Street Active pro-traders will be assisting investors today on GFA, INCY, ARNA and FBN, and provide insight based on their extensive experience so that you can boost your stock portfolio on the short-term or the long-term. If you are a shareholder in any of these companies do not miss this once in a life time opportunity, as our trading experts can show how to turn $5,000 into $35,000.
Gafisa S.A. (NYSE: GFA) closed at $4.92 on Monday, up 6.49%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Incyte Corporation (NASDAQ: INCY) closed at $19.22 on Monday, up 5.60%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Arena Pharmaceuticals Inc. (NASDAQ: ARNA) closed at $10.20 on Monday, up 5.60%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Furniture Brands International Inc. (NYSE: FBN) closed at $1.21 on Monday, up 5.22%. You could have made a profit on this equity, join us today and see how our veteran traders can help you double or triple your gains.
http://www.wallstreetactive.com/register.php
Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.
Source: Wall Street Active